Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Stevens-Johnson syndrome and HIV in children in Swaziland.

Dziuban EJ, Hughey AB, Stewart DA, Blank DA, Kochelani D, Draper HR, Schutze GE.

Pediatr Infect Dis J. 2013 Dec;32(12):1354-8. doi: 10.1097/INF.0b013e31829ec8e5.

PMID:
23743542
3.

Nevirapine and/or co-trimoxazole induced Stevens Johnson syndrome in HIV infected patient--a case report.

Patel K, Panchasara A, Purohit B, Tripathi CB.

Curr Drug Saf. 2013 Feb;8(1):72-4.

PMID:
23656450
4.

Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.

Lapphra K, Vanprapar N, Chearskul S, Phongsamart W, Chearskul P, Prasitsuebsai W, Chokephaibulkit K.

Int J Infect Dis. 2008 Nov;12(6):e33-8. doi: 10.1016/j.ijid.2007.10.008. Epub 2008 Jun 24.

5.

Comparative durability of nevirapine versus efavirenz in first-line regimens during the first year of initiating antiretroviral therapy among Swaziland HIV-infected adults.

Takuva S, Evans D, Zuma K, Okello V, Louwagie G.

Pan Afr Med J. 2013 May 3;15:5. doi: 10.11604/pamj.2013.15.5.1889. Print 2013.

6.

Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.

Fagot JP, Mockenhaupt M, Bouwes-Bavinck JN, Naldi L, Viboud C, Roujeau JC; EuroSCAR Study Group.

AIDS. 2001 Sep 28;15(14):1843-8.

PMID:
11579247
7.

Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine.

Metry DW, Lahart CJ, Farmer KL, Hebert AA.

J Am Acad Dermatol. 2001 Feb;44(2 Suppl):354-7.

PMID:
11174414
8.

Stevens-Johnson syndrome and toxic epidermal necrolysis in sub-Saharan Africa: a multicentric study in four countries.

Saka B, Barro-Traoré F, Atadokpédé FA, Kobangue L, Niamba PA, Adégbidi H, Yedomon HG, Traoré A, Pitché VP.

Int J Dermatol. 2013 May;52(5):575-9. doi: 10.1111/j.1365-4632.2012.05743.x. Epub 2013 Jan 20.

PMID:
23330601
9.

Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study.

Mittmann N, Knowles SR, Koo M, Shear NH, Rachlis A, Rourke SB.

Am J Clin Dermatol. 2012 Feb 1;13(1):49-54. doi: 10.2165/11593240-000000000-00000.

PMID:
22145749
10.

[Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].

Saka B, Kombaté K, Mouhari-Toure A, Akakpo S, Tchangaï-Walla K, Pitché P.

Med Trop (Mars). 2010 Jun;70(3):255-8. French.

PMID:
20734593
11.

Stevens-Johnson syndrome in an HIV-infected patient.

Blitz M, Spivack E, Kerpel SM, Freedman PD.

AIDS Read. 1999 May-Jun;9(3):184-5, 190.

PMID:
12728904
12.

Stevens Johnson Syndrome and Toxic Epidermal Necrolysis: Maternal and Foetal Outcomes in Twenty-Two Consecutive Pregnant HIV Infected Women.

Knight L, Todd G, Muloiwa R, Matjila M, Lehloenya RJ.

PLoS One. 2015 Aug 12;10(8):e0135501. doi: 10.1371/journal.pone.0135501. eCollection 2015.

13.
14.

Nevirapine-induced stevens johnson-syndrome and fulminant hepatic failure requiring liver transplantation.

Jao J, Sturdevant M, del Rio Martin J, Schiano T, Fiel MI, Huprikar S.

Am J Transplant. 2010 Jul;10(7):1713-6. doi: 10.1111/j.1600-6143.2010.03153.x.

15.

Effectiveness of efavirenz-based regimens in young HIV-infected children treated for tuberculosis: a treatment option for resource-limited settings.

van Dijk JH, Sutcliffe CG, Hamangaba F, Bositis C, Watson DC, Moss WJ.

PLoS One. 2013;8(1):e55111. doi: 10.1371/journal.pone.0055111. Epub 2013 Jan 25.

16.

Nevirapine toxicity in a cohort of HIV-1-infected pregnant women.

João EC, Calvet GA, Menezes JA, D'Ippolito MM, Cruz ML, Salgado LA, Matos HJ.

Am J Obstet Gynecol. 2006 Jan;194(1):199-202.

PMID:
16389032
17.

Predicting factors for unsuccessful switching from nevirapine to efavirenz in HIV-infected patients who developed nevirapine-associated skin rash.

Kiertiburanakul S, Malathum K, Watcharananan S, Sathapatayavongs B, Sungkanuparph S.

Int J STD AIDS. 2009 Mar;20(3):176-9. doi: 10.1258/ijsa.2008.008231.

PMID:
19255265
18.

Efavirenz replacement by immediate full-dose nevirapine is safe in HIV-1-infected patients in Cambodia.

Laureillard D, Prak N, Fernandez M, Ngeth C, Moeung S, Riel V, Chhneang V, Song S, Quillet C, Piketty C.

HIV Med. 2008 Aug;9(7):514-8. doi: 10.1111/j.1468-1293.2008.00597.x. Epub 2008 Jun 28.

19.

Stevens-Johnson syndrome associated with nevirapine use in an HIV-positive pregnant woman: a case report.

Agboghoroma CO, Uwaezuoke T, Jibrin PG.

West Afr J Med. 2010 May-Jun;29(3):187-9.

PMID:
20665464
20.

Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.

Mason AR, Cortes GY, Pollack RB.

Pediatr Dermatol. 2008 Jan-Feb;25(1):128-9. doi: 10.1111/j.1525-1470.2007.00605.x.

PMID:
18304177

Supplemental Content

Support Center